Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references

被引:0
|
作者
Valenzuela, Claudia [1 ]
Bonella, Francesco [2 ]
Moor, Catharina C. [3 ]
Weimann, Gerrit [4 ]
Miede, Corinna [5 ]
Stowasser, Susanne [4 ]
Maher, Toby M. [6 ,7 ]
机构
[1] Univ Autonoma Madrid, Hosp Univ La Princesa, Pulmonol Dept, Madrid, Spain
[2] Univ Hosp Essen, Ctr Interstitial & Rare Lung Dis, Pneumol Dept, Ruhrlandklin, Essen, Germany
[3] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands
[4] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[5] Mainanalyt GmbH, Sulzbach, Germany
[6] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[7] Imperial Coll London, London, England
关键词
D O I
10.1183/13993003.congress-2024.PA673
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone
    Kono, Masato
    Nakamura, Yutaro
    Enomoto, Noriyuki
    Saito, Go
    Koyanagi, Yu
    Miyashita, Koichi
    Tsutsumi, Akari
    Kobayashi, Takeshi
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Miki, Yoshihiro
    Hashimoto, Dai
    Fujisawa, Tomoyuki
    Inui, Naoki
    Suda, Takafumi
    Nakamura, Hidenori
    RESPIRATORY INVESTIGATION, 2019, 57 (06) : 552 - 560
  • [42] Nebulised pirfenidone in idiopathic pulmonary fibrosis (IPF): first look at FVC data
    West, Alex
    Lawrence, Alexandra
    Bao, Hao
    Nair, Deepthi
    Thompson, Courtney
    Woodhead, Felix
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] EFFECT OF PIRFENIDONE ON ALL-CAUSE MORTALITY (ACM) AND FORCED VITAL CAPACITY (FVC) IN IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS WITH LOW FVC AND/OR LOW DLCO: ANALYSIS OF POOLED DATA FROM ASCEND AND CAPACITY
    Nathan, S. D.
    Costabel, U.
    Albera, C.
    Kirchgaessler, K. U.
    Chou, W.
    Noble, P. W.
    THORAX, 2017, 72 : A254 - A254
  • [44] Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF)
    Cottin, Vincent
    Hansell, David M.
    Sverzellati, Nicola
    Weycker, Derek
    Antoniou, Katerina M.
    Atwood, Mark
    Oster, Gerry
    Kirchgaessler, Klaus-Uwe
    Wells, Athol U.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [45] Effect Of Pirfenidone On All-Cause Mortality (acm) And Forced Vital Capacity (FVC) In Idiopathic Pulmonary Fibrosis (ipf) Patients With Low FVC And/or Low Dlco: Analysis Of Pooled Data From Ascend And Capacity
    Nathan, S. D.
    Costabel, U.
    Albera, C.
    Kirchgassler, K. -U.
    Chou, W.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [46] Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis
    Watanabe, Kentaro
    Nagata, Nobuhiko
    Kitasato, Yasuhiko
    Wakamatsu, Kentaro
    Nabeshima, Kazuki
    Harada, Taishi
    Hirota, Takako
    Shiraishi, Motokimi
    Fujita, Masaki
    RESPIRATORY INVESTIGATION, 2012, 50 (03) : 88 - 97
  • [47] Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis
    Durheim, M. T.
    Collard, H. R.
    Roberts, R. S.
    Brown, K. K.
    Flaherty, K. R.
    King, T. E.
    Palmer, S. M.
    Raghu, G.
    Snyder, L. D.
    Anstrom, K. J.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [48] INHALED INTERFERON AND DIFFUSION CAPACITY IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Skaria, S. D.
    Yang, Jie
    Condos, Rany
    Smaldone, G. C.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (01) : 37 - 42
  • [49] Idiopathic Pulmonary Fibrosis (IPF): An Overview
    Barratt, Shaney L.
    Creamer, Andrew
    Hayton, Conal
    Chaudhuri, Nazia
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08)
  • [50] Sleep and idiopathic pulmonary fibrosis (IPF)
    Rasche, Kurt
    Leidag, Markus
    Orth, Maritta
    SOMNOLOGIE, 2020, 24 (01): : 11 - 15